BDBM620778 (3R,4R) or (3S,4S) 4-(4-(6-chloro- 2-((5-chloro-1-(difluoromethyl)- 1H-pyrazol-4-yl)amino)quinazolin- 7-yl)piperazin-1-yl)-4- methyltetrahydrofuran-3-ol::US20230303540, Example Ex-3.59

SMILES CC1(COCC1O)N1CCN(CC1)c1cc2nc(Nc3cnn(C(F)F)c3Cl)ncc2cc1Cl

InChI Key InChIKey=TWSJJYRNFDKNEU-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 620778   

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM620778((3R,4R) or (3S,4S) 4-(4-(6-chloro- 2-((5-chloro-1-...)
Affinity DataIC50:  0.178nMAssay Description:The LRRK2 kinase activity reported herein as IC50 values was determined with LanthaScreen technology from Life Technologies Corporation (Carlsbad, CA...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent